Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways

Peter J. Naus, Roger Henson, Grant Bleeker, Hania Wehbe, Fanyin Meng, Tushar Patel

Research output: Contribution to journalArticle

54 Scopus citations

Abstract

Background/Aims: Tannic acid is an orally active plant polyphenol with potential for use as an anti-cancer agent for cholangiocarcinoma. To determine the potential use of tannic acid as an adjunct therapy, we sought to evaluate the interaction between tannic acid and chemotherapeutic agents. Methods: Cytotoxicity was assessed in malignant human cholangiocytes. Interactions between tannic acid, mitomycin C, 5-fluorouracil and gemcitabine were quantitated by calculating the combination index and dose reduction index. Cellular efflux pathways were assessed by calcein retention assays, and expression of membrane pumps was assessed by Western blots and real-time PCR. Results: Tannic acid and the three agents decreased growth of malignant cholangiocytes to a similar extent. Tannic acid had a synergistic effect to mitomycin C and 5-fluorouracil, but not gemcitabine. However, the structurally related polyphenol gallic acid did not have a synergistic interaction with any of the agents. Tannic acid decreased calcein efflux and the expression of PGP, MRP1 and MRP2 membrane efflux pumps. Conclusions: Tannic acid has a synergistic effect with selected chemotherapeutic drugs by a mechanism involving modulation of drug efflux pathways. Thus, tannic acid will be a useful adjunct to improve the effectiveness of chemotherapeutic agents in the treatment of cholangiocarcinoma.

Original languageEnglish (US)
Pages (from-to)222-229
Number of pages8
JournalJournal of hepatology
Volume46
Issue number2
DOIs
StatePublished - Feb 1 2007

Keywords

  • Biliary cancers
  • Chemotherapy
  • Pharmacology
  • Plant polyphenol
  • Treatment

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways'. Together they form a unique fingerprint.

  • Cite this